Stoke Therapeutics Inc at JPMorgan Healthcare Conference Transcript
I mean, it was now I'm here for Jess because she's stuck trying to get out of Grand Ballroom fire hazard. And with us, we have on at our case, are the CYO. for stoke here to present on, please.
Thank you, Rocco, and good afternoon, everyone. And I hope everyone is surviving the third days of JPM and have a lot of energy left on. So I'm Edward K and I'm the CEO, so therapeutics and I will be making some forward-looking statements. So please refer to our SEC documents for further description what I want to talk to today really about is our program and Dr. A., this is what a drug a child looks like at birth. And for those of you lucky enough to have children. You remember that day as a newborn, and you're just very happy that they're healthy and they and they're happy. This is what Dr. a patient looks like six to nine months later. Unfortunately, this is a genetic disease that affects about one and 16,000 children and it occurs spontaneously. So you don't know that it runs in the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |